http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001233877-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14ecdea033d4e8f28cb8b348f9e19d54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22 |
| filingDate | 2000-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de99427790f331c5d19fbe26d671e46a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ea3798242765b9b1f8a22fb8d78751 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25eefc96481b8d955e92ae73a8ffe06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93c85b9a745b0c21d1844f6dfb5c5ea |
| publicationDate | 2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001233877-A |
| titleOfInvention | Phenylalkoxyporphyrin complex |
| abstract | PROBLEM TO BE SOLVED: To provide a porphyrin complex which maintains accumulation in tumor tissue and significantly reduces phototoxicity, and is suitable for a diagnostic agent for cancer by nuclear magnetic resonance imaging (MRI) and sensitization. Provide agent. SOLUTION: The following formula (I): [In the formula, one of R 1 and R 2 is —CH ＝ CH 2 or -CH (CH 3) when the OH, the other is -CH (C H 3 ) O- (CH 2 ) n-A, or both of them represent -CH (CH 3 ) O- (CH 2 ) n-A (however, Substituent A represents a phenyl group. Asp represents an aspartic acid residue; n is an integer of 1 to 3; A transition metal of Mn, Fe, Co or Cu] or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2000-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.